PeptideScanner retained ClinicalTrials.gov record NCT03439943 at 2026-07-30T18:19:48.216Z. Its registry update date was 2025-11-28, and PeptideScanner's reviewed identity mapping was lixisenatide. 1

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1